Profile
Sotirios G.
Stergiopoulos is the founder of A2a Pharmaceuticals, Inc., founded in 2016, where the title held is President & Chief Executive Officer.
Current jobs include Executive Chairman at Coiled Therapeutics Plc and Director at Ricovr Healthcare, Inc. Former jobs include Executive Director-US Medical Affairs Oncology at Celgene Corp.
(2014–2016), Deputy Director-Global Medical Affairs Oncology at Bayer Healthcare LLC (2009–2012), Senior Director-Global Brand Medical at Novartis AG (2012–2014), Independent Director at Biomea Fusion, Inc., Chief Medical Officer & Senior Vice President at Ipsen SA (2017–2019), Vice President & Head-Global Medical Affairs at Shire Plc (2016), Vice President & Head-Global Medical Affairs at Baxalta, Inc. (2016), and Chief Medical Officer & Senior Vice President at Ipsen Pharmaceuticals, Inc. (2017–2019).
Education includes undergraduate studies at Stony Brook University, graduate studies at The Johns Hopkins University, and a doctorate from Poznan University of Medical Science.
Sotirios Stergiopoulos active positions
| Companies | Position | Start |
|---|---|---|
| ROQT THER | Chairman | - |
A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs | Chief Executive Officer | 2019-07-01 |
Ricovr Healthcare, Inc.
Ricovr Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and sells oral diagnostic medical devices | Director/Board Member | - |
Former positions of Sotirios Stergiopoulos
| Companies | Position | End |
|---|---|---|
| IPSEN | Chief Tech/Sci/R&D Officer | 2019-05-31 |
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Chief Tech/Sci/R&D Officer | 2019-05-31 |
| BAXALTA INC | Corporate Officer/Principal | 2016-09-30 |
| SHIRE | Corporate Officer/Principal | 2016-09-30 |
| CELGENE | Corporate Officer/Principal | 2015-12-31 |
Training of Sotirios Stergiopoulos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Health Technology |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stony Brook University
Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Poznan University of Medical Science
Poznan University of Medical Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs | Technology Services |
Ricovr Healthcare, Inc.
Ricovr Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and sells oral diagnostic medical devices | Health Technology |
Roquefort Therapeutics Plc
Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Biomea Fusion, Inc.
Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
- Stock Market
- Insiders
- Sotirios Stergiopoulos
















